Tech Company Financing Transactions
WaVe Life Sciences Funding Round
WaVe Life Sciences closed a $18 million Series A funding round on 2/3/2015. Investors included RA Capital and private investors.
Transaction Overview
Company Name
Announced On
2/3/2015
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series A
Investors
RA Capital ( Peter Kolchinsky)
Proceeds Purpose
WaVe is using the cash to scale up, and get ready to bring its first drug to clinical trials. It's got 19 employees as of now.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
733 Concord Ave.
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Overview
WaVe Life Sciences (NASDAQ: WVE) is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structures. We and our strategic partners are advancing a portfolio of stereopure drug candidates that target underlying biology across a wide range of human diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Bolno
Chief Medical Officer
Michael Panzara
Vice President
Chandra Vargeese
VP - Bus. Development
Chris Francis
VP - Finance
Kyle Moran
Browse more venture capital transactions:
Prev: 2/2/2015: Genomind venture capital transaction
Next: 2/3/2015: Civitas Learning venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs